What We Do
In Indonesia, HP+ is generating critical data and evidence in close partnership with the Government of Indonesia that could be used by policymakers, key stakeholders, civil society, and the private sector to improve the development, implementation, and monitoring of the government's priority policies around maternal and newborn health, HIV, and health financing. Our activities include:
- Comprehensive assessment of JKN: HP+ is analyzing JKN's financial sustainability and the fiscal space to finance JKN in the context of rising healthcare spending; measuring JKN's impact on households (in particular, poor and near-poor households); capturing JKN's impact on providers' financial position and the quality and efficiency of healthcare service delivery with JKN; and considering the private sector and economic impact of JKN.
- Quantitative analysis of maternal and newborn health risk factors: HP+ is partnering with the Ministry of Health Research Institute (Badan Litbang Kemenkes) to understand the determinants of health-seeking behavior and access to and quality of services related to the continuum of care for maternal and newborn health. Through a variety of workshops and working sessions, HP+ is developing the capacity of Badan Litbang Kemenkes to conduct quantitative analysis to help inform evidence-based policymaking.
- Assessing national and subnational HIV resource requirements: HP+ generated comprehensive resource needs estimates for the national HIV response using updated targets and revised, province-specific unit costs and explored sustainable domestic financing options for HIV. At the subnational level, USAID is working in Jakarta and Papua to analyze the cost and health impact of scaling up HIV services to improve prevention and treatment cascades.
HP+ partnered with the National Team for Accelerating Poverty Reduction, known as TNP2K, and other actors within the Government of Indonesia to conduct a comprehensive assessment of JKN. The assessment considers the impact of JKN from four perspectives—the payer, patient, provider, and private sector.